U.S. FDA Approves Biocon Biologics' YESINTEK™, Bmab 1200 Biosimilar to J&J's Stelara® (Ustekinumab)
J&J(JNJ) Prnewswire·2024-12-02 20:00J&J(JNJ) Prnewswire·2024-12-02 20:00
R1J&J(JNJ) Prnewswire·2024-12-02 20:00 R1J&J(JNJ) Prnewswire·2024-12-02 20:00